As dietary FRB supplementation was able to alter the mRNA expression of both Il-22 and Il-17 (Figure 5B,C), it is possible that the tryptophan metabolites play a synergistic role with other bioactive compounds in FRB in ameliorating DSS-induced colitis and, subsequently, contribute to the prevention of the onset of fibrosis. This evidence concerns the gene IL17A and colitis.